American Gastroenterological Association Institute Guideline on the Pharmacological Management of Irritable Bowel Syndrome

Published:September 14, 2014DOI:
      This document presents the official recommendations of the American Gastroenterological Association (AGA) on the use of pharmacological agents for the treatment of irritable bowel syndrome (IBS) in adults. The guideline was developed by the Clinical Practice and Quality Measures Committee (currently the Clinical Practice Guideline Committee) and approved by the AGA Governing Board.

      Abbreviations used in this paper:

      AGA (American Gastroenterological Association), FDA (Food and Drug Administration), GRADE (Grading of Recommendations Assessment, Development and Evaluation), IBS (irritable bowel syndrome), IBS-C (irritable bowel syndrome with constipation), IBS-D (irritable bowel syndrome with diarrhea), RCT (randomized controlled trial)
      To read this article in full you will need to make a payment
      AGA Member Login
      Login with your AGA username and password.
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Purchase one-time access:

      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


      1. American Gastroenterological Association. AGA Institute clinical practice guideline development process. January 2013. Available at:

        • Sultan S.
        • Falck-Ytter Y.
        • Inadomi J.M.
        The AGA Institute process for developing clinical practice guidelines part one: grading the evidence.
        Clin Gastroenterol Hepatol. 2013; 11: 329-332
        • Institute of Medicine
        Clinical practice guidelines we can trust.
        Institute of Medicine, Washington, DC2011
        • Chang L.
        • Lembo A.
        • Sultan S.
        American Gastroenterological Association technical review on the pharmacological management of irritable bowel syndrome.
        Gastroenterology. 2014; 147: 1149-1172

      Linked Article

      • Correction
        GastroenterologyVol. 148Issue 2
        • Preview
          Weinberg DS, Smalley W, Heidelbaugh JJ, et al. American Gastroenterological Association Institute guideline on the pharmacological management of irritable bowel syndrome. Gastroenterology 2014;147:1146–1148.
        • Full-Text
        • PDF